(0.09%) 5 251.00 points
(0.00%) 39 643 points
(0.21%) 18 293 points
(-0.10%) $78.18
(-0.04%) $2.25
(-0.75%) $2 357.10
(-0.74%) $28.30
(-0.13%) $1 005.90
(-0.01%) $0.928
(0.20%) $10.85
(-0.04%) $0.798
(-0.52%) $92.19
@ $49.33
Issued: 14 Feb 2024 @ 15:32
Return: -36.26%
Previous signal: Feb 14 - 10:03
Previous signal:
Return: 2.08 %
Live Chart Being Loaded With Signals
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins...
Stats | |
---|---|
Today's Volume | 567 921 |
Average Volume | 732 172 |
Market Cap | 2.15B |
EPS | $-2.53 ( 2024-05-03 ) |
Next earnings date | ( $-1.410 ) 2024-05-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.20 |
ATR14 | $0.0280 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Berkowitz Noah | Buy | 93 879 | Stock Option (right to buy) |
2024-03-18 | Berkowitz Noah | Buy | 63 452 | Common Stock |
2024-03-18 | Berkowitz Noah | Buy | 0 | |
2024-02-29 | Teel Randy | Sell | 0 | Common Stock |
2024-02-29 | Teel Randy | Sell | 0 | Common Stock |
INSIDER POWER |
---|
45.23 |
Last 95 transactions |
Buy: 1 590 588 | Sell: 490 115 |
Volume Correlation
Arvinas Inc Correlation
10 Most Positive Correlations | |
---|---|
WSC | 0.911 |
XMTR | 0.905 |
PRSO | 0.902 |
TRS | 0.899 |
GMBL | 0.898 |
SELB | 0.898 |
SPTN | 0.898 |
AMNB | 0.897 |
ROIC | 0.896 |
ESSA | 0.895 |
10 Most Negative Correlations | |
---|---|
TVTY | -0.902 |
WLTW | -0.898 |
BTAQ | -0.897 |
SGEN | -0.893 |
USLM | -0.891 |
GPACU | -0.887 |
FRSG | -0.885 |
NVSA | -0.883 |
GVCI | -0.883 |
MLAI | -0.881 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Arvinas Inc Correlation - Currency/Commodity
Arvinas Inc Financials
Annual | 2023 |
Revenue: | $78.50M |
Gross Profit: | $71.80M (91.46 %) |
EPS: | $-6.62 |
FY | 2023 |
Revenue: | $78.50M |
Gross Profit: | $71.80M (91.46 %) |
EPS: | $-6.62 |
FY | 2022 |
Revenue: | $131.40M |
Gross Profit: | $123.20M (93.76 %) |
EPS: | $-5.11 |
FY | 2021 |
Revenue: | $46.00M |
Gross Profit: | $46.00M (100.00 %) |
EPS: | $-3.82 |
Financial Reports:
No articles found.
Arvinas Inc
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators